Chemical Works of Gedeon Richter (BUD:RICHTER) ROCE %

: 37.17% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chemical Works of Gedeon Richter's annualized ROCE % for the quarter that ended in Dec. 2023 was 37.17%.

Chemical Works of Gedeon Richter ROCE % Historical Data

The historical data trend for Chemical Works of Gedeon Richter's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

7.07

14.57

15.81

15.82

15.44

Chemical Works of Gedeon Richter Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																26.45	18.29	9.42	76.13	37.17

Chemical Works of Gedeon Richter ROCE % Calculation

Chemical Works of Gedeon Richter's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	186880	/	( ( (1353784 - 179507)	+	(1361217 - 114508) )	/ 2 )
	=	186880	/	( (1174277	+	1246709)	/ 2 )
	=	186880	/	1210493
	=	15.44 %

Chemical Works of Gedeon Richter's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	454552	/	( ( (1357434 - 158260)	+	(1361217 - 114508) )	/ 2 )
	=	454552	/	( ( 1199174	+	1246709 )	/ 2 )
	=	454552	/	1222941.5
	=	37.17 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Chemical Works of Gedeon Richter (BUD:RICHTER) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chemical Works of Gedeon Richter ROCE % Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

RGEDF:USA GEDSF:USA 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines